Performance of osteopontin in the diagnosis of malignant pleural mesothelioma: a meta-analysis

Hui Lin; Yong-Chun Shen; Hong-Yu Long; Hao Wang; Ze-Yu Luo; Zi-Xuan Wei; Shi-Qi Hu; Fu-Qiang Wen
June 2014
International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 5, p1289
Academic Journal
It is reported that osteopontin has shown promising diagnostic value for malignant pleural mesothelioma (MPM), this meta-analysis aimed to establish the overall diagnostic accuracy of the osteopontin measurement for diagnosing MPM. Based on a systematic review of English language studies, the sensitivity, specificity and other measures of accuracy of osteopontin in the diagnosis of MPM were pooled using random-effects model. Summary receiver operating characteristic curves were used to summarize overall test performance. Seven publications met our inclusion criteria, the pooled sensitivity was 0.57 (95%CI: 0.52-0.61), specificity was 0.81, 95%CI: 0.79-0.84). The PLR was 3.78 (95%CI: 2.23-6.41), the NLR was 0.51 (95%CI: 0.38-0.67) and the DOR was 9.04 (95%CI: 5.28-15.48), the area under the summary receiver operating characteristic curve was 0.80. Our data suggest that osteopontin is likely to be a useful diagnostic marker for MPM, considering for the limited studies and patients included, larger studies are needed to confirm these findings.


Related Articles

  • Osteopontin Impairs Host Defense during Established Gram-Negative Sepsis Caused by Burkholderia pseudomallei (Melioidosis). van der Windt, Gerritje J. W.; Wiersinga, W. Joost; Wieland, Catharina W.; Tjia, Ivo C. S. I.; Day, Nicholas P.; Peacock, Sharon J.; Florquin, Sandrine; van der Poll, Tom // PLoS Neglected Tropical Diseases;Aug2010, Vol. 4 Issue 8, p1 

    Background: Melioidosis, caused by infection with Burkholderia (B.) pseudomallei, is a severe illness that is endemic in Southeast Asia. Osteopontin (OPN) is a phosphorylated glycoprotein that is involved in several immune responses including induction of T-helper 1 cytokines and recruitment of...

  • Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-Analysis. Ranpura, Vishal; Pulipati, Bhargava; Chu, David; Xiaolei Zhu; Shenhong Wu // American Journal of Hypertension;May2010, Vol. 23 Issue 5, p460 

    BackgroundHypertension is associated with the use of bevacizumab, an angiogenesis inhibitor widely used in cancer therapy. Currently, the risk of severe hypertension associated with bevacizumab is unclear. We performed a systematic review and meta-analysis of published...

  • Diagnostic Accuracy of Calretinin for Malignant Mesothelioma in Serous Effusions: a Meta-analysis. Li, Diandian; Wang, Bo; Long, Hongyu; Wen, Fuqiang // Scientific Reports;3/27/2015, p9507 

    Numerous studies have investigated the utility of calretinin in differentiating malignant mesothelioma (MM) from metastatic carcinoma (MC) in serous effusions. However, the results remain controversial. The aim of this study is to determine the overall accuracy of calretinin in serous effusions...

  • Metachronous Malignant Mesothelioma and Pulmonary Adenocarcinoma. ÖZBUDAK, İrem Hicran; ÖZBUDAK, Ömer; ARSLAN, Gökhan; ERDOĞAN, Abdullah; ÖZBİLİM, Gülay // Turkish Journal of Pathology;Jan2013, Vol. 29 Issue 1, p83 

    The prevalence of multiple primary malignant neoplasms in a single patient is reported in a wide variation. The co-existence of malignant mesothelioma and pulmonary carcinoma is a rare entity. Herein, we reported a 60-year-old man who was a retired employee and heavy smoker. He had a suspicious...

  • Lymphangiomatoid pattern in diffuse malignant mesothelioma of the pleura: a report of six cases. Eugene Mark // Virchows Archiv;Aug2009, Vol. 455 Issue 2, p143 

    The multiplicity of epithelioid and mesenchymal forms of diffuse malignant mesothelioma includes patterns that may mimic another process. Identification of the multiplicity of patterns may help in the diagnosis of diffuse malignant mesothelioma. One pattern that has not been described is...

  • RETRACTED ARTICLE: Combined blood and pleural levels of mesothelin and osteopontin for the diagnosis of malignant pleural mesothelioma. Fathy, Mona; Ashour, Wafaa; Samir, Aisha; Zaki, Dalia // Comparative Clinical Pathology;May2014, Vol. 23 Issue 3, p493 

    No abstract available.

  • Prognostic significance of osteopontin in patients with lung cancer: a meta-analysis. Bin Peng; Yi-Han Wang; Zhuo Huang; Shi-Jian Feng; Yong-Sheng Wang // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 12, p4616 

    Both plasma/serum/pleural effusion osteopontin concentration (PSPO) and tumor tissue osteopontin expression (TTO) have recently been reported to be involved in the prognosis of lung cancer. In this study, we per-formed a meta-analysis to demonstrate the association between PSPO/TTO and survival...

  • Accurate Diagnosis of Mesothelioma. Allen, Timothy Craig // Archives of Pathology & Laboratory Medicine;May2013, Vol. 137 Issue 5, p601 

    The author reflects on the difficulty and the importance for doctors to diagnose malignant mesothelioma because it can be easily confused with other diseases. The author mentions that research is ongoing as to the specific molecular mechanisms by which asbestos exposure can cause diffuse...

  • Antiplatelet treatment in unstable angina: aspirin, clopidogrel, glycoprotein IIb/IIIa antagonist, or all three? Harding, S.A.; Boon, N.A.; Flapan, A.D. // Heart;Jul2002, Vol. 88 Issue 1, p11 

    Evidence on the role of antiplatelet agents in patients with non-ST elevation acute coronary syndrome is reviewed, and a strategy for their use in unstable angina is presented


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics